tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EKF Diagnostics Tightens Capital Structure with Targeted Share Buyback

Story Highlights
  • EKF Diagnostics repurchased 142,000 shares into treasury, refining its capital structure.
  • Targeted purchases from Harwood-managed funds keep director Mills’ stake below 30 percent.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EKF Diagnostics Tightens Capital Structure with Targeted Share Buyback

Claim 70% Off TipRanks Premium

EKF Diagnostics Holdings ( (GB:EKF) ) has issued an update.

EKF Diagnostics Holdings has repurchased 142,000 of its own ordinary shares at a weighted average price of 26.4 pence, placing the shares into treasury and leaving 433,685,112 shares in issue with voting rights, a move that marginally adjusts the company’s capital structure and provides a new denominator for major shareholding disclosures. As part of this buyback, EKF also acquired 42,000 shares from funds managed by Harwood to ensure that non-executive director Christopher Mills’ aggregate indirect holding, now 127,886,000 shares, remains around but below 30% of the company’s voting rights, addressing regulatory thresholds and preserving the existing balance of shareholder control.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £27.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.

EKF Diagnostics Holdings receives a score of 67, driven by strong financial performance and a positive earnings call. The company’s robust balance sheet and improved profitability are significant strengths. However, technical indicators suggest potential bearish momentum, and the valuation is moderate. The positive outlook from the earnings call, including strategic growth plans and a share buyback program, enhances the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings is an AIM-listed global diagnostics business focused on point-of-care analysers in hematology and diabetes, as well as life sciences services that manufacture specialist enzymes and custom products for diagnostic, food and industrial applications. Headquartered in Penarth near Cardiff, the company operates five manufacturing sites across the US and Germany and sells into more than 120 countries worldwide.

Average Trading Volume: 494,627

Technical Sentiment Signal: Strong Sell

Current Market Cap: £114.3M

See more data about EKF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1